These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29239894)

  • 1. Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors.
    Sadanand S; Das J; Chung AW; Schoen MK; Lane S; Suscovich TJ; Streeck H; Smith DM; Little SJ; Lauffenburger DA; Richman DD; Alter G
    AIDS; 2018 Feb; 32(4):443-450. PubMed ID: 29239894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.
    Banerjee K; Klasse PJ; Sanders RW; Pereyra F; Michael E; Lu M; Walker BD; Moore JP
    AIDS Res Hum Retroviruses; 2010 Apr; 26(4):445-58. PubMed ID: 20377426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design.
    Madhavi V; Wren LH; Center RJ; Gonelli C; Winnall WR; Parsons MS; Kramski M; Kent SJ; Stratov I
    AIDS; 2014 Aug; 28(13):1859-70. PubMed ID: 24937308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers.
    Lai JI; Licht AF; Dugast AS; Suscovich T; Choi I; Bailey-Kellogg C; Alter G; Ackerman ME
    J Virol; 2014 Mar; 88(5):2799-809. PubMed ID: 24352471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.
    Kant S; Zhang N; Barbé A; Routy JP; Tremblay C; Thomas R; Szabo J; Côté P; Trottier B; LeBlanc R; Rouleau D; Harris M; Dupuy FP; Bernard NF
    Front Immunol; 2020; 11():583820. PubMed ID: 33101312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
    Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
    Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24.
    Tjiam MC; Sariputra L; Armitage JD; Taylor JP; Kelleher AD; Tan DB; Lee S; Fernandez S; French MA
    AIDS; 2016 Nov; 30(18):2757-2765. PubMed ID: 27603291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-gp140-Specific Antibodies Generated From Indian Long-Term Non-Progressors Mediate Potent ADCC Activity and Effectively Lyse Reactivated HIV Reservoir.
    Dhande JR; Bagul RD; Thakar MR
    Front Immunol; 2022; 13():844610. PubMed ID: 35309295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine.
    McGuire EP; Fong Y; Toote C; Cunningham CK; McFarland EJ; Borkowsky W; Barnett S; Itell HL; Kumar A; Gray G; McElrath MJ; Tomaras GD; Permar SR; Fouda GG
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29021402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying Anti-HIV Envelope-Specific Antibodies in Plasma from HIV Infected Individuals.
    Kant S; Zhang N; Routy JP; Tremblay C; Thomas R; Szabo J; Côté P; Trottier B; LeBlanc R; Rouleau D; Harris M; Dupuy FP; Bernard NF
    Viruses; 2019 May; 11(6):. PubMed ID: 31141927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.
    Chung AW; Mabuka JM; Ndlovu B; Licht A; Robinson H; Ramlakhan Y; Ghebremichael M; Reddy T; Goulder PJR; Walker BD; Ndung'u T; Alter G
    AIDS; 2018 Jun; 32(10):1207-1217. PubMed ID: 29620716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens.
    Karnasuta C; Akapirat S; Madnote S; Savadsuk H; Puangkaew J; Rittiroongrad S; Rerks-Ngarm S; Nitayaphan S; Pitisuttithum P; Kaewkungwal J; Tartaglia J; Sinangil F; Francis DP; Robb ML; de Souza MS; Michael NL; Excler JL; Kim JH; O'Connell RJ; Karasavvas N
    AIDS Res Hum Retroviruses; 2017 May; 33(5):410-423. PubMed ID: 28006952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort.
    Fink E; Fuller K; Agan B; Berger EA; Saphire A; Quinnan GV; Elder JH
    AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1187-1197. PubMed ID: 27771962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.
    Madhavi V; Wines BD; Amin J; Emery S; ; Lopez E; Kelleher A; ; Center RJ; Hogarth PM; Chung AW; Kent SJ; Stratov I
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28701393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers.
    Buranapraditkun S; Pissani F; Teigler JE; Schultz BT; Alter G; Marovich M; Robb ML; Eller MA; Martin J; Deeks S; Michael NL; Streeck H
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential IgG subclass responses to epitopes in transmembrane protein of HIV-1.
    Klasse PJ; Blomberg J; Pipkorn R
    Viral Immunol; 1990; 3(2):89-98. PubMed ID: 1694431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
    Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG subclass responses to human immunodeficiency virus-1 antigens: lack of IgG2 response to gp41 correlates with clinical manifestation of disease.
    Lal RB; Heiba IM; Dhawan RR; Smith ES; Perine PL
    Clin Immunol Immunopathol; 1991 Feb; 58(2):267-77. PubMed ID: 1985797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.
    Ngo-Giang-Huong N; Candotti D; Goubar A; Autran B; Maynart M; Sicard D; Clauvel JP; Agut H; Costagliola D; Rouzioux C;
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1435-46. PubMed ID: 11679156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of immunoglobulin G subclass reactivity to HIV-1 envelope peptides in children born to HIV-1-infected mothers.
    Jansson M; Wahren B; Scarlatti G; Principi N; Lombardi V; Livadiotti S; Elia L; Plebani A; Wigzell H; Rossi P
    AIDS; 1992 Apr; 6(4):365-71. PubMed ID: 1616634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.